Daria D. Vanina

Daria D. Vanina

Auto-generated profile, based on publicly available information

Daria D. Vanina

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2022 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
VPV. I. Podzolkov
V. I. Podzolkov
ATA. I. Tarzimanova
A. I. Tarzimanova
ABAnna E. Bragina
Anna E. Bragina
ILIrakli Loriya
Irakli Loriya
APA. E. Pokrovskaya
A. E. Pokrovskaya
DVD. D. Vanina
D. D. Vanina
Early diagnosis of atrial fibrillation (AF) predictors in coronavirus disease 2019 (COVID-19) and the appointment of additional therapy to prevent arrhythmias will improve the prognosis of patients.Aim. To identify predictors of AF in patients with COVID-19.Material and methods. This retrospective study included 1473 patients hospitalized with COVID-19. Depending on AF occurrence, the patients were divided into 2 groups as follows: group I included 95 patients with AF episodes during hospitalization; group II consisted of 1378 patients who did not have AF during hospitalization. All patients underwent a complete blood count and urine tests, a biochemical and coagulation blood tests, 12-lead electrocardiography, chest computed tomography (CT), and echocardiography.Results. Chest CT found that lung tissue involvement in patients of group I was significantly greater than in group II (p50% (CT-3 and CT-4) was significantly higher in the AF group than in the control group. The average room air oxygen saturation upon admission to the hospital were significantly lower in patients with AF than in the comparison group (p60 years, hypertension, coronary artery disease, heart failure, increased left atrial volume, large lung tissue involvement, and increased interleukin- 6 level.Conclusion. There are two following groups of predictors initiating AF in COVID-19: generally known (older age, cardiovascular disease, increased left atrial volume) and those that determine the severe COVID-19 course (large lung damage and high interleukin-6 levels).

28 April 2023 in Rational Pharmacotherapy in Cardiology
Verified
Journal Article
Open access
PDF file
VPV. I. Podzolkov
V. I. Podzolkov
APA. E. Pokrovskaya
A. E. Pokrovskaya
DVD. D. Vanina
D. D. Vanina
ISI. I. Shvedov
I. I. Shvedov
Aim. To study the association of the level of endothelial dysfunction marker sVCAM-1 with the severe course of COVID-19.Material and methods. The study included 100 patients with COVID-19, who were divided into 3 groups depending on the degree of lung damage based on the results of computed tomography (CT): group CT 1 – 29 patients, group CT 2 – 61 patients and the group CT 3 – 10 patients. In addition to the standard examination performed for coronavirus infection, all patients underwent carotid Doppler ultrasound, analysis of arterial stiffness indices (CAVI, ABI) using the VaSera device, and evaluation of the plasma sVCAM-1 concentration by ELISA.Results. The plasma sVCAM-1 concentration was significantly higher in the groups of patients with moderately severe (CT 2) and severe (CT 3) lung lesions than in patients with mild lesions (CT 1). In the general group of patients significant correlations were found between the plasma sVCAM-1 concentration and the level of oxygen saturation (r=-0.39, p=0.032), hospital length of stay (r=0.24, p=0.026), values of C-reactive protein (r=0.25, p=0.042), ferritin (r=0.38, p=0.021), LDH (r=0.52, p=0.015) , as well as the percentage of pulmonary involvement according to CT data at admission (r=0.41, p=0.019) and on the day of discharge (r=0.35, p=0.022). According to multivariate regression analysis, sVCAM-1 does not depend upon gender, age, body mass index (BMI), the presence of type 2 diabetes mellitus (T2DM) and hypertension, and is a marker associated with cytokine storm progression, intermediate negative dynamics according to CT data, and need for respiratory support. The presence of type 2 diabetes, as well as elevated sVCAM-1 concentrations, is associated with an increased risk of high-dose glucocorticosteroid therapy. The threshold levels of this marker were calculated for each of the above events. We revealed a correlation between the sVCAM-1 concentration and the carotid intimal medial thickness in the general group of patients (r=0.25, p=0.036).Conclusion. An increase in the plasma sVCAM-1 concentration reflects the progression of endothelial dysfunction, one of the key factors in the pathogenesis of COVID-19. The latter necessitates the need for endothelium protective therapy for these patients. The evaluation of sVCAM-1 in blood plasma is a promising diagnostic technique aimed at predicting the risk of a severe course of COVID-19 and its long-term health hazards.

20 March 2022 in Russian Open Medical Journal
Verified
Journal Article
Closed access
VPValery I. Podzolkov
Valery I. Podzolkov
APAnna E. Pokrovskaya
Anna E. Pokrovskaya
UBUlyana S. Bazhanova
Ulyana S. Bazhanova
DVDaria D. Vanina
Daria D. Vanina
TVTatiana S. Vargina
Tatiana S. Vargina
The urgency of obesity issue is undeniable. Obesity is now considered the most important risk factor of cardiovascular diseases. Numerous studies have demonstrated the negative effect of excessive adipose tissue on structural and functional changes in the heart that lead to development of left ventricular hypertrophy, arrhythmias and conduction abnormalities, as well as progression of diastolic and systolic heart failure. High prevalence of obesity – so high that it can be called a pandemic – greatly contributes to the increased incidence of cardiovascular diseases. Studying the problem of obesity is a priority area of focus for modern medicine. This article describes hormonal, metabolic and hemodynamic features of obesity impact on cardiovascular system and describes pathogenetic mechanisms of cardiovascular pathology development.

10 January 2021 in Open Access Macedonian Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
VPValery Podzolkov
Valery Podzolkov
APAnna Pokrovskaya
Anna Pokrovskaya
UBUlyana Bazhanova
Ulyana Bazhanova
TVTatyana Vargina
Tatyana Vargina
SKSvetlana Anatolievna Knyazeva
Svetlana Anatolievna Knyazeva
DVDaria Vanina
Daria Vanina
The recent decades saw a steady growth of obesity incidence worldwide. Obesity is an independent risk factor for cardiovascular diseases (CVDs) and type 2 diabetes mellitus and is also associated with a shorter life expectancy. Not only hemodynamic but also hormone metabolic processes, arising from excessive accumulation of adipose tissue in human body, underlie the development of CVDs. Adipose tissue has now been proved to be a hormone-active substrate. Studies of the influence of adipokines will bring us closer to understanding cardiovascular pathogenesis and help personalize prophylactic strategies.

27 June 2025 in Systemic Hypertension
Verified
Journal Article
Open access
PDF file
APA. E. Pokrovskaya
A. E. Pokrovskaya
DVD. D. Vanina
D. D. Vanina
VIV. S. Ivanova
V. S. Ivanova
KKK. E. Krylova
K. E. Krylova
ASA. R. Solomatova
A. R. Solomatova
VPV. I. Podzolkov
V. I. Podzolkov
Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver diseases. According to modern concepts, a unique feature of this pathology is that patients with NAFLD have a significantly increased risk of developing not only liver diseases, but also extrahepatic pathologies, mainly cardiovascular diseases (CVD). Various studies have clearly demonstrated the predictive role of NAFLD in the development of arterial hypertension, coronary heart disease, myocardial infarction, cardiac arrhythmias, and cardiovascular mortality. The commonality of pathogenetic mechanisms underlying NAFLD and CVD is discussed, primarily such as: dyslipidemia, hypertriglyceridemia, insulin resistance, lipotoxicity and chronic sterile inflammation. This review article analyzes the relationship between NAFLD and CVDs, describes the pathophysiological mechanisms of the bidirectional influence of these pathologies.

30 November 2022 in Kardiologiia
Verified
Journal Article
Open access
PDF file
VPV. I. Podzolkov
V. I. Podzolkov
DVD. D. Vanina
D. D. Vanina
APA. E. Pokrovskaya
A. E. Pokrovskaya
NDN. A. Dragomiretskaya
N. A. Dragomiretskaya
VKV. V. Kozlov
V. V. Kozlov
Aim      To study early manifestations of left ventricular (LV) and right ventricular (RV) myocardial remodeling in high-risk patients. Material and methods  Intracardiac hemodynamics was studied by equilibrium radionuclide ventriculography (ERVG) in 83 patients (mean age, 61.1±8.9 years) with preserved LV ejection fraction according to echocardiography data, a body weight index (BWI) >25 kg /m 2 , obesity, and type 2 diabetes mellitus (DM2). Parameters of intracardiac hemodynamics were compared in patients with different degrees of obesity and DM2 durations in age groups of younger and older than 60 years. Results All patients had both LV and RV diastolic dysfunction. The diastolic dysfunction progressed with age and DM2 duration, primarily by the restrictive type. The increase in BWI, in contrast, was associated with increases in ventricular volumetric parameters. It was noted that specifically modifiable risk factors (obesity and DM2), but not the age, mostly facilitated the impairment of RV relaxation. Conclusion      The strategy of normalizing the body weight and carbohydrate metabolism is priority in combatting the development and progression of chronic heart failure in high-risk group patients.